Long-term safety and efficacy evaluation of lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP study

Trial Identifier: LTS18300
Sponsor: Sanofi
Start Date: May 2025
Primary Completion Date: January 2031
Study Completion Date: January 2031
Condition: Nose and Sinus Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.